BR100 Increased By (1.9%)
BR30 Increased By (1.3%)
KSE100 Increased By (1.66%)
KSE30 Increased By (1.87%)
AGHA 7.46 Increased By ▲ 0.01 (0.13%)
BECO 5.27 Increased By ▲ 0.03 (0.57%)
BML 57.26 Increased By ▲ 0.52 (0.92%)
BOP 34.75 Increased By ▲ 1.05 (3.12%)
CNERGY 11.06 Increased By ▲ 0.05 (0.45%)
CSIL 5.83 Decreased By ▼ -0.03 (-0.51%)
FCCL 56.42 Increased By ▲ 1.28 (2.32%)
FFL 16.41 Increased By ▲ 0.31 (1.93%)
FNEL 1.20 No Change ▼ 0.00 (0%)
KEL 7.32 Increased By ▲ 0.06 (0.83%)
KOSM 6.15 Increased By ▲ 0.14 (2.33%)
LOTCHEM 27.12 Increased By ▲ 0.21 (0.78%)
MLCF 97.94 Increased By ▲ 2.01 (2.1%)
NBP 206.88 Increased By ▲ 3.60 (1.77%)
NCPL 56.42 Increased By ▲ 0.69 (1.24%)
NPL 65.77 Increased By ▲ 0.72 (1.11%)
OGDC 316.30 Increased By ▲ 2.19 (0.7%)
PACE 10.87 Increased By ▲ 0.38 (3.62%)
PAEL 42.30 Increased By ▲ 0.38 (0.91%)
PIBTL 16.78 Increased By ▲ 0.04 (0.24%)
PPL 220.69 Increased By ▲ 2.97 (1.36%)
PRL 63.65 Increased By ▲ 0.95 (1.52%)
PTC 71.82 Increased By ▲ 0.36 (0.5%)
SSGC 27.08 Increased By ▲ 0.34 (1.27%)
TBL 9.72 Increased By ▲ 0.06 (0.62%)
TELE 8.73 Increased By ▲ 0.25 (2.95%)
TPL 19.40 Decreased By ▼ -0.58 (-2.9%)
TPLP 14.78 Decreased By ▼ -0.16 (-1.07%)
TREET 23.40 Increased By ▲ 0.33 (1.43%)
TRG 61.41 Increased By ▲ 0.74 (1.22%)
By

Medplus Health Services one of India’s top retail pharmacy chains, reported a 43.3% rise in second-quarter profit on Friday, driven by higher sales from new store openings and steady demand for its private label products.

Consolidated net profit rose to 555 million Indian rupees ($6.31 million) for the quarter ended September 30, up from 387 million rupees a year ago.

Total revenue rose 6.5% to 16.79 billion Indian rupees ($191.02 million).

The company, which operates over 4,200 pharmacies in India, has been expanding into smaller cities and plans to open 600 new stores by the end of this fiscal year.

It trails Apollo Pharmacy, which has more than 6,000 stores, and also competes with Reliance Industries’ Netmeds and other retail pharmacies.

MedPlus is benefitting from growing demand for its high-margin private label products in both the pharmaceuticals and consumer wellness categories.

The pharmacy chain is also offering online sale and at-home delivery of medicines, keeping up with the growing appetite for convenience among Indian customers.

Comments

Comments are closed for this article.